Jazz Pharmaceuticals plc — Director's Dealing 2020

Nov 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2020-11-04

Reporting Person: Sohn Catherine A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-04	Ordinary Shares	M	4500	$81.76	Acquired	15122	Direct
2020-11-04	Ordinary Shares	S	4500	$156.0	Disposed	10622	Direct
2020-11-04	Ordinary Shares	M	8000	$46.83	Acquired	18622	Direct
2020-11-04	Ordinary Shares	S	8000	$152.0	Disposed	10622	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-04	Non-Qualified Stock Option (right to buy)	$46.83	M	8000	Disposed	2022-08-08	Ordinary Shares (8000)	Direct
2020-11-04	Non-Qualified Stock Option (right to buy)	$81.76	M	4500	Disposed	2023-08-07	Ordinary Shares (4500)	Direct

Footnotes

F1: This non-qualified stock option was granted on August 9, 2012. The ordinary shares subject to this option award vested over 1 year in 12 equal monthly installments and were fully vested as of August 9, 2013.

F2: This non-qualified stock option was granted on August 8, 2013. The ordinary shares subject to this option award vested over 1 year in 12 equal monthly installments and were fully vested as of September 1, 2014.